top of page

EADV 2023 Day 3 Afternoon: Efficacy and Safety of Rezpegaldesleukin

Writer: Jeremy VisserJeremy Visser

Dr. Fiona Lovegrove reports live from the 2023 EADV Congress in Berlin and discusses the late breaking presentation on rezpegaldesleukin.



 
 
 

コメント


bottom of page